Suppr超能文献

[2015年中国子宫体癌的发病率和死亡率]

[Incidence and mortality of corpus uteri cancer in China, 2015].

作者信息

Ma J Y, Zhou Y, Lin Y T, Xiang Z S, Zheng R S, Zhang S W, Wang S M, Chen R, Wei W W, He J

机构信息

Fujian Provincial Office for Tumor Prevention and Control, Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou 350014, China.

Office for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.

出版信息

Zhonghua Zhong Liu Za Zhi. 2021 Jan 23;43(1):108-112. doi: 10.3760/cma.j.cn112152-20200423-00373.

Abstract

To estimate the incidence and mortality of corpus uteri cancer in China, 2015. Quality audit and evaluation of the data from 2015 cancer registration reported by 501 cancer registries were conducted, and 368 cancer registries were included in the analysis. The incidence rate and mortality rate of corpus uteri cancer were calculated according to the factors of the region (urban, rural, east, central, western), sex and age groups. The incidence and mortality of corpus uteri cancer with the 2015 population were estimated. Chinese standard population in 2000 and world Segi's population were used for the calculation of age-standardized rates (ASR) of incidence and mortality. In 2015, 368 cancer registries included in the analysis covered a total of 309 553 499 populations in China, accounting for 22.52% of the national population. It is estimated that there were about 68 900 new cases of corpus uteri cancer in 2015, the incidence rate was 10.28/10(5), age-standardized incidence rates by Chinese standard population (ASR China) and world standard population (ASR world) were 6.86/10(5) and 6.66/10(5), respectively. The incidence rate of urban area (11.35/10(5)) was higher than that of rural area (8.90/10(5)), and the incidence of eastern region (12.12/10(5)) was higher than the central region (9.94/10(5)) and the western region (8.25/10(5)). It is estimated that in 2015, there were about 16 000 deaths of corpus uteri cancer, the mortality rate was 2.39/10(5), ASR China was 1.49/10(5), ASR world was 1.47/10(5). The mortality in urban areas (2.40/10(5)) is close to rural areas (2.39/10(5)); the mortality in central areas (2.55/10(5)) was higher than the eastern areas (2.32/10(5)) and the western areas (2.31/10(5)). In China, the incidence of corpus uteri cancer is on the rise and has a trend of youth, the burden of disease is gradually increasing, which threatens the health of women. Targeted prevention and control measures should be carried out in the different regions.

摘要

估算2015年中国子宫体癌的发病率和死亡率。对501个癌症登记处上报的2015年癌症登记数据进行质量审核与评估,纳入分析的有368个癌症登记处。根据地区(城市、农村、东部、中部、西部)、性别和年龄组等因素计算子宫体癌的发病率和死亡率。估算2015年子宫体癌的发病数和死亡数。采用2000年中国标准人口和世界Segi人口计算发病率和死亡率的年龄标准化率(ASR)。2015年,纳入分析的368个癌症登记处覆盖中国总人口309553499人,占全国人口的22.52%。估计2015年子宫体癌新发病例约68900例,发病率为10.28/10万,中国标准人口年龄标准化发病率(ASR中国)和世界标准人口年龄标准化发病率(ASR世界)分别为6.86/10万和6.66/10万。城市地区发病率(11.35/10万)高于农村地区(8.90/10万),东部地区发病率(12.12/10万)高于中部地区(9.94/10万)和西部地区(8.25/10万)。估计2015年子宫体癌死亡病例约16000例,死亡率为2.39/10万,ASR中国为1.49/10万,ASR世界为1.47/1'0万。城市地区死亡率(2.4'0/10万)与农村地区相近(2.39/10万);中部地区死亡率(2.55/10万)高于东部地区(2.32/10万)和西部地区(2.31/10万)。在中国,子宫体癌发病率呈上升趋势且有年轻化趋势,疾病负担逐渐加重,威胁着女性健康。应在不同地区开展针对性的防控措施。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验